Yuneisy Ruiz Haquia
Adult Health · Miami, FLNPI 1689096943
Payments from drug & device makers
Across 362 payments — averaging $20.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Lilly USA, LLC$1K
- Novo Nordisk$911
- Boehringer Ingelheim$736
- Biohaven Pharmaceuticals, Inc.$389
- Amarin Pharma, Inc.$356
- plus $2K from 25 others
What the payments were for
- Food & beverage$7,388100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 53 | $1,460 |
| Lilly USA, LLC | 66 | $1,094 |
| Novo Nordisk | 57 | $911 |
| Boehringer Ingelheim | 30 | $736 |
| Biohaven Pharmaceuticals, Inc. | 10 | $389 |
| Amarin Pharma, Inc. | 25 | $356 |
| Exact Sciences | 13 | $292 |
| AbbVie | 21 | $270 |
| Bayer | 8 | $262 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $223 |
| GSK | 4 | $181 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $148 |
| Kowa Pharmaceuticals America, Inc. | 6 | $113 |
| Sanofi-aventis U.S. LLC | 5 | $109 |
| Abbott | 3 | $95 |
| Pfizer | 5 | $90 |
| Eisai Inc. | 5 | $84 |
| Novartis | 5 | $84 |
| Idorsia Pharmaceuticals US Inc | 3 | $58 |
| Amgen | 3 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $49 |
| Amneal Pharmaceuticals LLC | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Ardelyx, Inc. | 2 | $44 |
| Radius Health, Inc. | 2 | $42 |
| Johnson & Johnson | 3 | $38 |
| Biogen | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Corcept Therapeutics | 1 | $21 |
| Astellas Pharma US Inc | 1 | $18 |
| IBSA Pharma Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,388 in reported general payments places this provider in the 95th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JentaduetoLinagliptin/Metformin Hcl | 24 | $24,301 |
| OzempicSemaglutide | 22 | $23,393 |
| JanumetSitagliptin Phos/Metformin Hcl | 16 | $21,901 |
| MounjaroTirzepatide | 21 | $20,835 |
| FarxigaDapagliflozin Propanediol | 14 | $20,146 |
| TradjentaLinagliptin | 13 | $18,784 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $8,175 |
| LivaloPitavastatin Calcium | 12 | $7,780 |
| VascepaIcosapent Ethyl | 16 | $6,787 |
| SynthroidLevothyroxine Sodium | 28 | $3,511 |
| Dexlansoprazole DrDexlansoprazole | 16 | $2,840 |
| Rosuvastatin Calcium | 130 | $1,719 |
| Omeprazole | 71 | $1,451 |
| Atorvastatin Calcium | 117 | $995 |
| Fluticasone Propionate | 59 | $986 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJentadueto, Tradjenta | $736 | $43,08637 claims |
| Novo NordiskOzempic | $911 | $23,39322 claims |
| Lilly USA, LLCMounjaro | $1,094 | $20,83521 claims |
| AstraZenecaFarxiga | $1,460 | $20,14614 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $113 | $7,78012 claims |
| AbbVieSynthroid | $270 | $3,51128 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $48 | $83056 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,237 adult health providers in Florida.
Other adult health in Miami
- Norma SolisMiami$150K
- Jeffrey HernandezMiami$122K
- Kristen NievesMiami$16K
- Jose ChamorroMiami$15K
- Wendy KaysMiami$13K
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Ashley PontenbergWinter Park$136K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.